February 17, 2021 – Western Maine Health, affiliated with MaineHealth which is the largest health care organization in Maine and a leading health care provider serving northern New Hampshire, recently adopted the EyeArt® system for diabetic eye screening in the Western Maine Primary Care clinic. This adoption is part of a national trend toward automated point-of-care detection of diabetic retinopathy by leveraging the FDA-cleared autonomous artificial intelligence (AI) technology. Diabetic eye screening in the primary care setting provides convenience to diabetic patients and empowers providers to maximize reimbursement with improved 5-Star and HEDIS quality ratings. Medicare recently announced CY2021 reimbursement fee ($55.66) for hospital outpatient use of automated point-of-care retinal exams (CPT code 92229).
“Ensuring patients with diabetes receive an annual eye exam is often challenging logistically for providers, especially those in rural areas,” said Dr. Brian M. Nolan, MD of Western Maine Primary Care. “I look forward to improving care for our diabetic patients with the implementation of the EyeArt system in our primary care clinic.”